Top Medical Searches

Tygacil (tigecycline): Label Change – Increased Mortality Risk

Audience: Infectious Disease, Critical Care Medicine, Internal Medicine ISSUE: FDA reminded healthcare professionals of an increased mortality risk associated with the use of the intravenous antibacterial Tygacil (tigecycline) compared to that of…


Read More..

September 2nd, 2010

Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal – Risk of Thromboembolic Events

Audience: Risk Manager, Hematology, Pharmacy
ISSUE: Octapharma USA Inc. initiated a voluntary market withdrawal of selected lots of Octagam [Immune Globulin Intravenous (human)] 5% Liquid Preparation as a result of an increased number of reported…


Read More..

August 26th, 2010

MasXtreme Capsules (Natural Wellness) – product contains undeclared drug ingredient

Audience: Consumers, Pharmacists [UPDATED 08/25/2010] Natural Wellness notified consumers it is conducting a nationwide voluntary recall of MasXtreme, Lot # 907043, UPC 094922300805. Laboratory analysis conducted by FDA determined the product…


Read More..

August 26th, 2010

TimeOut Capsules: Undeclared Drug Ingredient

Audience: Consumers ISSUE:  FDA analyzed TimeOut and determined that it contains hydroxythiohomosildenafil, a chemical similar to sildenafil, the active ingredient in Viagra. Like sildenafil, this chemical may interact with prescription drugs…


Read More..

August 26th, 2010

Mr. Magic Male Enhancer: Undeclared Drug Ingredient

Audience: Consumers
ISSUE: Lab analysis has found Mr. Magic to contain hydroxythiohomosildenafil and sulfoaildenafil, an analogue of Sildenafil, an FDA-approved drug used as treatment for male Erectile Dysfunction (ED), making the product an…


Read More..

August 25th, 2010

Stalevo(carbidopa/levodopa and entacapone): Ongoing Safety Review: Possible increased cardiovascular risk

Audience: Neurology, Cardiology Issue: FDA notified healthcare professionals that it is evaluating clinical trial data that suggest patients taking Stalevo (a combination of carbidopa/levodopa and entacapone) may be at an increased risk for…


Read More..

August 21st, 2010

Midodrine hydrochloride: FDA Proposes Withdrawal of Low Blood Pressure Drug

Audience: Cardiology and Nephrology ISSUE: FDA proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition, orthostatic hypotension, because required post-approval studies that verify the…


Read More..

August 17th, 2010

Prolatis’: Undeclared Drug Ingredient

Audience: Consumers [Posted 08/13/2010]

ISSUE: Lab analysis has found Prolatis’ to contain Sulfoaildenafil, an analogue of Sildenafil, an FDA-approved drug used as treatment for male Erectile Dysfunction (ED), making Prolatis’ an…


Read More..

August 17th, 2010

Lamictal (lamotrigine): Label Change – Risk of Aseptic Meningitis

Audience: Pediatrics, Neurology, Psychiatry ISSUE: FDA notified healthcare professionals and patients that Lamictal (lamotrigine), a medication commonly used for seizures in children two years and older, and bipolar disorder in adults, can cause…


Read More..

August 12th, 2010

Lamictal (lamotrigine): Label Change – Risk of Aseptic Meningitis

Audience: Pediatrics, Neurology, Psychiatry ISSUE: FDA notified healthcare professionals and patients that Lamictal (lamotrigine), a medication commonly used for seizures in children two years and older, and bipolar disorder in adults, can cause…


Read More..

August 12th, 2010

Novacare LLC Products: Recall – Undeclared Drug Ingredient

Audience: Consumers Products sold under the following names: Stiff Nights, Aziffa, Size Matters, Erex, Mojo, Hard Drive, Eyeful, Red Magic, Straight Up, Zotrex, Monster Excyte, WOW, Xaitrex, Verect, Prolatis, Xytamax, Maxyte, Libidinal, OMG, OMG45,…


Read More..

August 12th, 2010

Revivexxx Extra Strength: Recall – Undeclared Drug Ingredient

Audience: Consumer
ISSUE: FDA lab analysis of Revivexxx Extra Strength was found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making Revivexxx Extra Strength an unapproved…


Read More..

August 10th, 2010

Solo Slim, Solo Slim Extra Strength: Recall – Undeclared Drug Ingredient

Audience: Cardiology, Consumer ISSUE: FDA lab analysis of Solo Slim was found to contain the undeclared drug ingredient Didesmethyl Sibutramine. Sibutramine is an FDA-approved drug used as an appetite suppressant for weight loss. This poses a threat…


Read More..

August 10th, 2010

Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy – Risk of serious hematological reactions

Audience: Primary Care, Infectious Disease
[UPDATED 08/04/2010] Dear Healthcare Professional Letter issued.
[Posted 07/08/2010]
ISSUE: Due to continued reports of serious side effects in patients using Qualaquin “off-label” for night time leg…


Read More..

August 5th, 2010

NeoProfen (ibuprofen lysine) Injection: Recall and Shortage – Risk of Particulate Matter

Audience: Cardiovascular Surgery, Anesthesia, Pharmacy
ISSUE: FDA notified healthcare professionals of a recall of two lots of NeoProfen (ibuprofen lysine) Injection because the product failed to meet a visible particulate quality requirement….


Read More..

August 3rd, 2010
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us